Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-231433
Filing Date
2012-05-14
Accepted
2012-05-14 16:32:32
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d323434d10q.htm 10-Q 280083
2 SECTION 302 PEO AND PFO CERTIFICATION d323434dex31.htm EX-31 8562
3 SECTION 906 PEO AND PFO CERTIFICATION d323434dex32.htm EX-32 4571
  Complete submission text file 0001193125-12-231433.txt   1569791

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nviv-20120331.xml EX-101.INS 173834
5 XBRL TAXONOMY EXTENSION SCHEMA nviv-20120331.xsd EX-101.SCH 14868
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nviv-20120331_cal.xml EX-101.CAL 31188
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nviv-20120331_def.xml EX-101.DEF 77779
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nviv-20120331_lab.xml EX-101.LAB 104403
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nviv-20120331_pre.xml EX-101.PRE 93039
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 (617) 475-1520
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52089 | Film No.: 12839124
SIC: 3841 Surgical & Medical Instruments & Apparatus